AgingResearch.News
Frontiers in Cardiovascular Medicine

Triglyceride-glucose index and the progression of chronic obstructive pulmonary disease, panvascular disease, and multimorbidity: a prospective cohort study

By Shuo Zhang, Xiaotian Li, Jiajing Li, Show 4 more authorsShuduo Zhou
Figure 1. Flowchart showing participant selection for a UK Biobank study: 502,422 participants initially, 155,387 excluded for medical history, 50,217 excluded for missing TyG data, leaving 296,818 eligible…
Open the figure at full size
Figure 1. Flowchart showing participant selection for a UK Biobank study: 502,422 participants initially, 155,387 excluded for medical history, 50,217 excluded for…Flowchart showing participant selection for a UK Biobank study: 502,422 participants initially, 155,387 excluded for medical history, 50,217 excluded for missing TyG data, leaving 296,818 eligible for analysis.Zhang et al.
Cohort study of 296,818 peoplePopulations

Declared no competing interests

Paper

The paper

Shuo Zhang, Xiaotian Li, Jiajing Li, Show 4 more authorsShuduo Zhou

Peking University First Hospital

Frontiers in Cardiovascular Medicine, 26 Aug 2026

doi.org/10.3389/fcvm.2026.1855099PubMed 42719026

More on Triglyceride-glucose index